Navigation Links
Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Date:8/19/2007

on Systems in the first half of 2007 versus two in the first half of 2006. Also contributing to this increase in revenue was an increase in the number of PULSE Tubes that were sold, revenue from Barocycler instruments under lease, and the recognition of extended service contract revenue. In addition to revenue received from the sale of PCT products and services, the Company also recorded $159,451 of grant revenue during the first half of 2007. The majority of this revenue was billed pursuant to the Company's SBIR Phase 1 grant for the development of novel protein extraction methods based on the Company's patented pressure cycling technology (PCT). During the same period in 2006, the Company did not record any grant revenue.

As of June 30, 2007, the Company had cash and cash equivalents of approximately $6.8 million, as compared to approximately $5.3 million on December 31, 2006. Edward H. Myles, Senior Vice President of Finance and CFO, commented: "During the second quarter of 2007, we completed two transactions that strengthened our balance sheet, namely: (1) the liquidation of all our remaining shares in Panacos Pharmaceuticals common stock, and (2) the full divestiture of Source Scientific, LLC. These transactions resulted in the receipt of approximately $3.0 million of cash during the quarter. This cash will be used to support a number of important Company activities, including various research and development programs and our previously announced PCT product line commercialization plan."

Richard T. Schumacher, Founder, President, and CEO of Pressure BioSciences, Inc. said: "In addition to improving our balance sheet through the Source and Panacos transactions, other notable achievements of our second quarter included: (1) record revenue driven by the sale of four PCT Sample Preparation Systems; (2) the release of the Barocycler NEP2320 as both a demonstration unit and commercial product; (3) approval to CE Mark the Barocycler NEP3229; (4) the develo
'/>"/>

SOURCE Pressure BioSciences, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. The Analysis of Polycyclic Aromatic Hydrocarbons (PAHs) by LC/MS/MS Using an Atmospheric Pressure Photoionization Source
2. Determination of N-nitrosamines in Baby Bottle Rubber Teats by Liquid Chromatography-Atmospheric Pressure Chemical Ionization Mass Spectrometry
3. Screening of Corticosteroids in Urine by Negative Atmospheric Pressure Chemical Ionization LC/MS/MS
4. Medical College receives $11 million grant to study high blood pressure
5. Pressure mounts for Doyle to repeal shareholder liability law
6. Probe into gas gouging may educate Americans about pressures on oil supply
7. SWIB gets more pressure to invest in state tech start-ups
8. Technology puts pressure on old education methods
9. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
10. Sonic Foundry reports GAAP loss as Q2 revenues rise
11. Fiserv reports $113.5 million in Q1 profit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Die Übersetzungen wurden von PRNewswire ... der englischen Version handelt es sich um ... Teilnehmer einer groß angelegten Asthmaumfrage halten ihren Zustand für ... -Definition [1] als kontrolliert gelten können ... von vier Denkweisen zugeordnet werden können, die alle von ...
(Date:5/23/2013)... 2013 Venaxis, Inc. (Nasdaq:   APPY), an ... FDA clearance and commercializing its rapid, protein biomarker-based appendicitis ... an underwritten public offering of 10,000,000 shares of its ... of its common stock at an exercise price of ... of $1.25 per share and related warrant.  Venaxis has ...
(Date:5/23/2013)... Can economic incentives such as gift ... of the public to increase their donations of blood? ... Carey Business School Assistant Professor Mario Macis says ... large body of recent research that supports their argument, ... issue of Science that the World Health Organization and ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Patheon ... manufacturing services to the global pharmaceutical industry, will host ... Novel Approaches to Testing” on Tuesday, June 4, 2013 ... pharmaceutical manufacturers are required to comply with regulations for ... practices with limited scientific underpinning and little evaluation of ...
Breaking Biology Technology:Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 3Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 4Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 6Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 7Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2
... Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now... -- DALLAS, November 1, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed ...
... ... ... var shortURL ... we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; break; } for ...
... hundreds of FDA inspectors; now it trains thousands of ... global team of FDA compliance experts, EduQuest is presenting ... training course for quality managers and regulatory specialists December ... (near I-95, Amtrak rail lines, and the Philadelphia airport). ...
Cached Biology Technology:Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 2Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 3Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 4Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 5Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 6Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 7Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 8Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 9Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 10Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 11Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 2Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 3Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 4Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 5Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 6Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 7Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 8Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 9Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 10Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 11Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 12Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 13Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Comply with Latest FDA Expectations for Validation and Part 11 2
(Date:5/24/2013)... grow by avoiding detection and destruction by the immune ... eliminate cancer cells; however, there are many factors that ... T cells are immune cells that function to suppress ... Journal of Clinical Investigation , researchers led by ... cells that infiltrate tumors express proteins that can be ...
(Date:5/24/2013)... from around the world today issued a stark warning ... one or two generations, the majority of the 9 ... handicap of severe pressure on fresh water, an absolutely ... This handicap will be self-inflicted and is, we believe, ... underlying problems led by mismanagement and sent a prescription ...
(Date:5/23/2013)... than 284 million tons of cargo, transit the Panama Canal ... for the Panama Canal Authority. Each time a ship passes ... from Gatun Lake, which is also a source of water ... , However, the advent of very large "super" cargo ships, ... has demanded change. The Panama Canal is being expanded to ...
Breaking Biology News(10 mins):A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3
... NOVEMBER 16, 2009 Experts in soil science and representatives ... Congressional educational briefing, "The Essence of Earth and Wine: Terroir" ... House Office Building (Gold Room). Experts in ... -- how the balance of vineyard management and soil site ...
... Oak Ridge, Tenn., Nov. 16, 2009 -- An ... by the Department of Energy has made the "Jaguar" ... Laboratory, Jaguar is the scientific research community,s most powerful ... most difficult problems. The upgrade, funded with $19.9 million ...
... most people, you probably think chemistry is too difficult to ... any fun. But chemistry offers a magic and elegance to ... the fundamentals of digestion (as when good pizza goes bad!) ... Monty L. Fetterolf, both professional chemists and experienced educators, challenge ...
Cached Biology News:Soil experts to discuss terroir, the link between Earth, wine on Nov. 19 in DC 2Oak Ridge 'Jaguar' supercomputer is World's fastest 2Oak Ridge 'Jaguar' supercomputer is World's fastest 3Explore the science of familiar things -- and discover the 'Joy of Chemistry' 2
Carrier Serum...
The Lambda Control Kit contains lambda DNA and two 25mer primers, which can be used to amplify a 500bp fragment. The lambda DNA is purified by CsCl gradient centrifugation and organic extraction foll...
A robust formulation of Taq Polymerase supplied with a 10X colored reaction buffer which allows Direct Gel-Loading...
... Klein Taq is a derivative of ... N-terminally truncated Thermus aquaticus DNA polymerase. Expressed ... translation initiates at Met236, bypassing the 5'-3' ... The enzyme reveals a highly active and ...
Biology Products: